Aspen Pharmacare Holdings Limited - Trading Statement
Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Reg. No 1985/022935/06)
Share Code: APN ISIN: ZAE000066692
Trading Statement
In terms of paragraph 3.4(b) of the Listings Requirements of JSE Limited (`the
JSE Listings Requirements`) a listed company is required to publish a trading
statement as soon as it is satisfied that a reasonable degree of certainty
exists that the financial results for the period to be reported upon next will
differ by at least 20% from those of the previous corresponding period.
Aspen is expecting an increase of between 35% and 45% in earnings per share and
between 30% and 40% in headline earnings per share for the year ended 30 June
2005 compared to those of the previous year. Headline earnings per share are
adjusted to exclude the amortisation of goodwill.
The anticipated higher percentage increase in earnings per share growth as
compared with the percentage growth in headline earnings per share is mainly due
to the adoption of accounting standard `IFRS3 (AC140) Business Combinations` for
the year ended 30 June 2005. Consequently goodwill will not be amortised in
Aspen`s results for the 2005 year. Aspen`s audited results for the year ended
30 June 2004 recorded goodwill amortisation of R13.8 million.
The financial results on which this trading statement has been based have not
been reviewed or reported on by Aspen`s external auditors. The release of the
final announcement of results for the year ended 30 June 2005 is expected to be
published on or about 22 August 2005.
By order of the Board
21 July 2005
Sponsor: Investec Bank Limited
Date: 21/07/2005 04:30:04 PM
Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
